The Norwegian Competition Authority accepted a merger in the health food and supplements sector, subject to the divestment of two business units carved out from the target (Orkla/Collett Pharma)

The operation On 15 June 2005 Orkla ASA acquired the entire share capital of Collett Pharma AS from investment funds of Ferd Private Equity (Ferd). Orkla is a supplier of branded consumer goods to the Nordic grocery market, and operates in the branded consumer goods, materials, renewable energy and financial

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.